Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor David Kavanagh

Newcastle AuthorsTitleYearFull text
Professor David Kavanagh
Cocaine-associated atypical haemolytic uraemic syndrome in a genetically susceptible individual2020
Dr Tom Altmann
Dr Stephen Owens
Dr Dipayan Mitra
Professor Neil Sheerin
Professor David Kavanagh
et al.		Complement Factor I deficiency: a potentially treatable cause of fulminant cerebral inflammation2020
Professor David Kavanagh
Efficacy and Safety of the Long-Acting C5 Inhibitor, Ravulizumab, in Adult Patients with Atypical Hemolytic Uremic Syndrome Naïve to Complement Inhibitor Treatment2020
Dr Vicky Brocklebank
Dr Kate Smith-Jackson
Dr Patrick Walsh
Dr Kevin Marchbank
Professor Claire Harris
et al.		Long-term outcomes and response to treatment in DGKE nephropathy2020
Thomas Hallam
Dr Kevin Marchbank
Professor Claire Harris
Victoria Shuttleworth
Professor David Kavanagh
et al.		Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration2020
Dr Veronique Fremaux-Bacchi
Professor David Kavanagh
C3 glomerulopathy — understanding a rare complement-driven renal disease2019
Dr Kate Smith-Jackson
Dr Yi Yang
Harriet Denton
Katie Cooke
Professor David Kavanagh
et al.		Hyper-functional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice 2019
Dr Christopher Duncan
Dr Benjamin Thompson
Dr Rui Chen
Dr Florian Gothe
Victoria Shuttleworth
et al.		Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT22019
Dr Patrick Walsh
Professor David Kavanagh
Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism2018
Professor Claire Harris
Professor David Kavanagh
Dr Ruyue Sun
Developments in anti-complement therapy; from disease to clinical trial2018
1234567891011